Table 1 Clinicopathological characteristics
Variable | Value |
|---|---|
Gender, n (%) | |
Male | 47 (48.9) |
Female | 45 (51.1) |
Age, n (%) | |
< 65 | 75 (81.5) |
≥ 65 | 17 (18.5) |
BMI (kg/m2), median (range) | 22.0 (15.6–32.1) |
KPS, n (%) | |
< 80 | 14 (15.2) |
≥ 80 | 78 (84.8) |
History of prior surgery, n (%) | |
No | 38 (41.3) |
Yes | 54 (58.7) |
History of IV/IP chemotherapy, n (%) | |
No | 45 (48.9) |
Yes | 47 (51.1) |
History of targeted therapy, n (%) | |
No | 65 (70.7) |
Yes | 27 (29.3) |
Increased preoperative TMsa, n (%) | |
No | 28 (30.4) |
Yes | 64 (69.6) |
PCI score, n (%) | |
< 20 | 26 (28.3) |
≥ 20 | 66 (71.7) |
CC score, n (%) | |
0/1 | 48 (52.2) |
2/3 | 44 (47.8) |
Ascites (mL), n (%) | |
0 | 19 (20.7) |
0–1000 | 16 (17.4) |
> 1000 | 57 (62.0) |
Pathological type, n (%) | |
Epithelioid | 75 (81.5) |
Non-epithelioid | 17 (18.5) |
Vascular tumor emboli, n (%) | |
No | 67 (72.8) |
Yes | 25 (27.2) |
Lymphatic metastasis, n (%) | |
No | 82 (89.1) |
Yes | 10 (10.9) |
Ki-67 index, n (%) | |
≤ 9% | 15 (16.3) |
> 9% | 77 (83.7) |
SAEs, n (%) | |
No | 63 (68.5) |
Yes | 29 (31.5) |